{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:09:17Z","timestamp":1760983757748},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Libyan Government"},{"name":"Parkinson's Disease Society of Great Britain"},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline PLC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.brainres.2010.07.060","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T04:50:11Z","timestamp":1280897411000},"page":"236-242","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The effects of dose and route of administration of PSI on behavioural and biochemical indices of neuronal degeneration in the rat brain"],"prefix":"10.1016","volume":"1354","author":[{"given":"Salma","family":"Bukhatwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bai-Yun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Jenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2010.07.060_bb0005","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ana.20937","article-title":"Proteasome inhibition and Parkinson's disease modelling","volume":"60","author":"Bove","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2010.07.060_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.brainres.2010.07.060_bb0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2010.07.060_bb0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1471-4159.2009.05956.x","article-title":"An immunohistochemical and stereological analysis of PSI-induced nigral neuronal degeneration in the rat","volume":"109","author":"Bukhatwa","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2010.07.060_bb0025","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1074-5521(01)00056-4","article-title":"Proteasome inhibitors: from research tools to drug candidates","volume":"8","author":"Kisselev","year":"2001","journal-title":"Chem. Biol."},{"key":"10.1016\/j.brainres.2010.07.060_bb0030","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ana.20935","article-title":"Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys","volume":"60","author":"Kordower","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2010.07.060_bb0035","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.20938","article-title":"Lack of nigrostriatal pathology in a rat model of proteasome inhibition","volume":"60","author":"Manning-Bog","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2010.07.060_bb0040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","article-title":"Proteasomal function is impaired in substantia nigra in Parkinson's disease","volume":"297","author":"McNaught","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2010.07.060_bb0045","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/00001756-200208070-00018","article-title":"Proteasome inhibition causes nigral degeneration with inclusion bodies in rats","volume":"13","author":"McNaught","year":"2002","journal-title":"NeuroReport"},{"key":"10.1016\/j.brainres.2010.07.060_bb0050","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1471-4159.2002.00821.x","article-title":"Impairment of the ubiquitin\u2013proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures","volume":"81","author":"McNaught","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2010.07.060_bb0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.20186","article-title":"Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease","volume":"56","author":"McNaught","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2010.07.060_bb0060","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ana.20936","article-title":"Proteasome inhibitor-induced model of Parkinson's disease","volume":"60","author":"McNaught","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2010.07.060_bb0065","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2006.03.003","article-title":"Intragastric proteasome inhibition induces alpha-synuclein-immunopositive aggregations in neurons in the dorsal motor nucleus of the vagus in rats","volume":"401","author":"Miwa","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"suppl 10","key":"10.1016\/j.brainres.2010.07.060_bb0070","first-page":"LB-12","article-title":"Proteasome inhibitors cause a progressive model of Parkinson's disease in mice","volume":"20","author":"Nair","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2010.07.060_bb0075","first-page":"M603950200","article-title":"p53 Mediates non-transcriptional cell death in dopaminergic cells in response to proteasome inhibition","author":"Nair","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2010.07.060_bb0080","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.brainres.2010.07.060_bb0085","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.expneurol.2006.07.010","article-title":"Comparison of the neurotoxic effects of proteasomal inhibitors in primary mesencephalic cultures","volume":"202","author":"Reaney","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2010.07.060_bb0090","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1471-4159.2001.00474.x","article-title":"Proteasomal inhibition leads to formation of ubiquitin\/alpha-synuclein-immunoreactive inclusions in PC12 cells","volume":"78","author":"Rideout","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2010.07.060_bb0095","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.20934","article-title":"Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons","volume":"60","author":"Schapira","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2010.07.060_bb0100","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuro.2006.06.006","article-title":"Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models","volume":"27","author":"Sun","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.brainres.2010.07.060_bb0105","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.20932","article-title":"Reproducible nigral cell loss after systemic proteasomal inhibitor administration to rats","volume":"60","author":"Zeng","year":"2006","journal-title":"Ann. Neurol."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899310016501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899310016501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T16:00:44Z","timestamp":1588780844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899310016501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":21,"alternative-id":["S0006899310016501"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2010.07.060","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}